| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/15/2006 | US20060128619 Therapeutic use of modulators of notch |
| 06/15/2006 | US20060128013 Directed differentiation of embryonic cells |
| 06/15/2006 | US20060127927 Mammalian IAP gene family, primers, probes, and detection methods |
| 06/15/2006 | US20060127914 Nicotinic acetylcholine receptor |
| 06/15/2006 | US20060127894 Protein associated with cell growth, differentiation, and death |
| 06/15/2006 | US20060127509 Methods of reducing beta-amyloid polypeptides |
| 06/15/2006 | US20060127464 Female hormone-containing patch |
| 06/15/2006 | US20060127411 Immune -modulating peptide made of s.aureus enterotoxin b |
| 06/15/2006 | CA2591330A1 1, 2, 3, 3a, 8, 8a-hexahydro-2, 7a-diada-cyclopenta [a] inden-7-one derivatives which bind to neuronal nicotinic acetylcholine specific receptor sites and are useful in modulatingcholinergic function and in the treatment of addictive disorders |
| 06/15/2006 | CA2590177A1 Glyponectin (glycosylated adiponectin) for the treatment of diseases and conditions |
| 06/15/2006 | CA2589196A1 Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease |
| 06/15/2006 | CA2589192A1 Phenyl-piperazin methanone derivatives |
| 06/15/2006 | CA2587940A1 Benzdioxane piperazine derivatives with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
| 06/15/2006 | CA2587936A1 Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
| 06/15/2006 | CA2587928A1 Phenylpiperazines with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites |
| 06/15/2006 | CA2587559A1 Aryloxyethylamine derivatives with a combination of partial d0pamine-d2 receptor agonism and serotonin reuptake inhibition |
| 06/15/2006 | CA2587381A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 06/15/2006 | CA2587357A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 06/15/2006 | CA2587202A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 06/14/2006 | EP1669756A2 Prevention and treatment of amyloid-associated disorders |
| 06/14/2006 | EP1669352A1 Thiazoline derivative and use of the same |
| 06/14/2006 | EP1669350A1 Novel piperidine derivative |
| 06/14/2006 | EP1669089A1 INHIBITION OF NERVE CELL DEATH BY INHIBITING DEGRADATION OF SHC3, ATF6 OR CREBL1 BY HtrA2 AND METHOD OF AMELIORATING NEURODEGENERATIVE DISEASES |
| 06/14/2006 | EP1669085A1 Medical agent for prevention and/or treatment of alzheimer disease |
| 06/14/2006 | EP1669081A1 Apoptotic entities for use in treatment of T-cell-mediated und inflammatory disorders |
| 06/14/2006 | EP1669078A1 Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside RB 1 |
| 06/14/2006 | EP1669066A1 Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient |
| 06/14/2006 | EP1669065A1 Drug containing (2r)-2-propyloctanoic acid as the active ingredient |
| 06/14/2006 | EP1668016A1 Ligands |
| 06/14/2006 | EP1668003A1 Benzisoxazoles |
| 06/14/2006 | EP1667993A1 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 06/14/2006 | EP1667990A2 New compounds |
| 06/14/2006 | EP1667984A1 Gamma-secretase inhibitors |
| 06/14/2006 | EP1667970A1 Heterocyclic- or aryloxy, -thio 0r -amino substituted indoles-2-carboxylic acids or esters as pai-1 inhibitors |
| 06/14/2006 | EP1667969A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors |
| 06/14/2006 | EP1667770A2 Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro [3a,3,2][ 2]- benzazepine, method for the production thereof and use thereof in the production of medicaments |
| 06/14/2006 | EP1667769A2 Use of galanthamine and the derivatives thereof in the production of medicaments |
| 06/14/2006 | EP1667731A1 Bispecific oligonucleotide for the treatment of cns malignancies |
| 06/14/2006 | EP1667723A1 Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness |
| 06/14/2006 | EP1667695A2 Oligonucleotides targeting prion diseases |
| 06/14/2006 | EP1667686A1 Combination of serotonin reuptake inhibitors and norepinephrine reuptake inhibitors |
| 06/14/2006 | EP1667672A1 Method for preventing and/or treating neurodegenerative diseases |
| 06/14/2006 | EP1578746B1 Oxazoles as mglur1 enhancer |
| 06/14/2006 | EP1506190B1 (imidazol-1-yl-methyl)-pyridazine as nmda receptor blocker |
| 06/14/2006 | EP1476434B1 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 06/14/2006 | EP1471931A4 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1381373B1 Medical compositions for use in the treatment or prevention of a functional vitamin b12 deficienfcy |
| 06/14/2006 | EP1379650B1 Preferred segments of neural thread protein and methods of using the same |
| 06/14/2006 | EP1349550B1 Substituted-4-quinolones for the treatment of autoimmune diseases |
| 06/14/2006 | EP1347778B1 Behavior chemotherapy |
| 06/14/2006 | EP1343746B1 Use of carboxylic acid compound having cyclopropane ring as medicament |
| 06/14/2006 | EP1313457B1 Transdermal therapeutic system for releasing venlafaxine |
| 06/14/2006 | EP1309564B1 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 06/14/2006 | EP1278529B1 Therapeutic uses for mesenchymal stromal cells |
| 06/14/2006 | EP1268418B1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 06/14/2006 | EP1266227B1 Synergistic activation of regulatory elements by rel proteins and a steroid receptor |
| 06/14/2006 | EP1261361B1 Oral, nasal and pulmonary dosage formulations of copolymer 1 (glatiramer acetate) |
| 06/14/2006 | EP1261338B1 Compositions and methods for treatment of epilepsy |
| 06/14/2006 | EP1255558B1 Anti-april antibodies and hybridoma cells |
| 06/14/2006 | EP1248606B1 Use of fumaric acid derivatives for treating mitochondrial diseases |
| 06/14/2006 | EP1248595A4 Multi-step drug dosage forms |
| 06/14/2006 | EP1214324B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/14/2006 | EP1210100B1 Method of treating traumatic brain using non-steroidal anti-inflammatory drugs |
| 06/14/2006 | EP1165085B1 Phthalazine derivatives for treating inflammatory diseases |
| 06/14/2006 | EP1135115B1 Use of sibutramine for the treatment of disorders of the central nervous system secondary to organic impairments |
| 06/14/2006 | EP0750509B2 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES |
| 06/14/2006 | EP0699236B2 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 06/14/2006 | DE3844992B4 Acetyl:cholinesterase inhibitor compsns. for trans:dermal application - contg. substd. phenyl carbamate, e.g. new (s)-3-(1-di:methylamino-e thyl)phenyl N-ethyl-N-methyl-carbamate |
| 06/14/2006 | CN1788002A Biaryl substituted triazoles as sodium channnel blockers |
| 06/14/2006 | CN1787997A 4-arylsulphonylpiperidine derivatives for antagonism of the 5-HT2A receptor |
| 06/14/2006 | CN1787825A External patch containing estrogen and/or progestogen |
| 06/14/2006 | CN1787821A A method of treating an anxiety disorder |
| 06/14/2006 | CN1787820A Composition for improving cognition and memory |
| 06/14/2006 | CN1785982A New benzothiazine and benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 06/14/2006 | CN1785972A Premedicine acting on nervous centralis system |
| 06/14/2006 | CN1785409A Medicine for treating epilepsy clonus, child convulsion, prosopospasm and its preparation method |
| 06/14/2006 | CN1785372A Biotaseed fast dispersion solid preparation and its preparation method |
| 06/14/2006 | CN1785370A Medicine for treating facial paralysis spasm |
| 06/14/2006 | CN1785324A Medicinal composition for treating aphronesia and preparing process thereof |
| 06/14/2006 | CN1785313A Medicinal preparation for heart brain healting and its preparation method |
| 06/14/2006 | CN1785290A Lumbar invigorating kidney fortifying fast dispersion solid medicine and its preparation method |
| 06/14/2006 | CN1785281A Quality control method of spirit quieting oral liquid preparation |
| 06/14/2006 | CN1785272A Medicinal composition and its preparation method |
| 06/14/2006 | CN1785266A Nacortics stopping medicine |
| 06/14/2006 | CN1785216A Medicinal composition contg. total ginkgo flavone, its prepn. method and use |
| 06/14/2006 | CN1785201A Panaxsaponin composition, prepn. method and use thereof |
| 06/14/2006 | CN1785200A Notogisennoside composition, prepn. method and application thereof |
| 06/14/2006 | CN1785199A Helicid dripping pills and its prepn. method |
| 06/14/2006 | CN1785191A Zalaipulong injection |
| 06/14/2006 | CN1785171A Tablets contg. salviol gel as matrix |
| 06/14/2006 | CN1785167A Method for preparing composite delayed-release prepn. of non-narcotic analgesic |
| 06/14/2006 | CN1785056A Sobering tea and its prepn. method |
| 06/14/2006 | CN1259365C High friction coefficient rubber composite brake shoes |
| 06/14/2006 | CN1259332C C2,5'-disubstituted and N6, C2, 5' trisubstituted adenosine derivatives and their different uses |
| 06/14/2006 | CN1259329C Kaempferol derivative and its medicinal use |
| 06/14/2006 | CN1259316C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/14/2006 | CN1259107C Composition of half solid framework preparation of ginkgo leaf extract product |
| 06/14/2006 | CN1259085C Sapid invigorating yang capsule and the preparation thereof |